Optimizing the risk threshold of lymph node involvement for performing extended pelvic lymph node dissection in prostate cancer patients: a cost-effectiveness analysis.
CONCLUSION: Applying a WTP threshold of €20.000, completely omitting ePLND in CaP patients is cost-effective compared to other risk-based strategies. However, applying a 20% threshold for probable LNI to the Briganti 2012 nomogram or the Memorial Sloan Kettering Cancer Center web-calculator, may be a feasible alternative, in particular when higher WTP values are considered.
PMID: 33121913 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Hueting TTA, Cornel EEB, Korthorst RRA, Pleijhuis RRG, Somford DDM, van Basten JJPA, van der Palen JJAM, Koffijberg HH Tags: Urol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Netherlands Health | Prostate Cancer | Study | Urology & Nephrology